Casma Therapeutics Announces CEO Transition
31 Jan 2023 //
BUSINESSWIRE
Casma Therapeutics Raises $46.0 M in Series C Funding
15 Nov 2022 //
BUSINESSWIRE
Casma Therapeutics to Present at UBS 2022 Global Healthcare Conference
17 May 2022 //
GLOBENEWSWIRE
Casma Tx to Participate at 21st Annual Needham Virtual Healthcare Conference
07 Apr 2022 //
GLOBENEWSWIRE
Casma Therapeutics to Present at the UBS Virtual Biotechnology Symposium
16 Sep 2021 //
GLOBENEWSWIRE
Casma Therapeutics Announces Addition of S. Tooze to Scientific Advisory Board
13 Sep 2021 //
GLOBENEWSWIRE
Casma Therapeutics and Vipergen Enter Into Drug Discovery Agreement
01 Dec 2020 //
BUSINESSWIRE